This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting neurological disorders, such as epilepsy and Parkinson’s disease, due to its structural similarity to gamma-aminobutyric acid (GABA), a neurotransmitter. Additionally, it is employed in the development of enzyme inhibitors and receptor modulators, contributing to advancements in the treatment of metabolic and psychiatric conditions. Its trifluorophenyl group enhances binding affinity and stability, making it valuable in drug design and optimization.